Company intelligence / Profile preview
Sanofi Pasteur
Lyon, France
- Ownership
- Private
- Employees
- ~15000
- Development stage
- Other
01
Overview
Sanofi Pasteur is the global vaccines business unit of Sanofi, serving as one of the world's largest producers of vaccines. It produces over 1 billion doses annually, protecting against more than 20 infectious diseases. Recent highlights include the successful commercialization of Beyfortus (nirsevimab) for RSV prevention in infants and the advancement of next-generation mRNA-based influenza vaccines.
- Therapeutic areas
- Infectious Diseases
- Modalities
- VaccinemRNA-based drugsRecombinant proteinMonoclonal antibodyBiologic
- Industry
- Pharma
02
Drug pipeline
282 assets281 more assets in the full pipeline.
Request access →03
Partnerships
Beyond the preview
Go deeper on Sanofi Pasteur.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sanofi Pasteur.